NASDAQ:CPIX Cumberland Pharmaceuticals (CPIX) Stock Price, News & Analysis → Chances are you know the firms on this list (From WealthPress) (Ad) Free CPIX Stock Alerts $1.39 -0.04 (-2.80%) (As of 06/7/2024 08:51 PM ET) Add Compare Share Share Today's Range$1.39▼$1.4350-Day Range$1.40▼$1.7852-Week Range$1.39▼$2.36Volume1,800 shsAverage Volume11,003 shsMarket Capitalization$19.72 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Cumberland Pharmaceuticals alerts: Email Address Ad Wealthpin ProThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. About Cumberland Pharmaceuticals Stock (NASDAQ:CPIX)Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.Read More CPIX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CPIX Stock News HeadlinesJune 3, 2024 | americanbankingnews.comCumberland Pharmaceuticals (NASDAQ:CPIX) Research Coverage Started at StockNews.comMay 29, 2024 | msn.com2 people injured in Cumberland County plane crash identifiedMay 29, 2024 | msn.comSheriff's Office to pull resource, traffic officers from most Cumberland County SchoolsMay 29, 2024 | msn.comBGMU hoping to have portion of Cumberland Trace Road open by the weekendMay 28, 2024 | msn.comCumberland County dispatcher awarded for helping to deliver babyMay 28, 2024 | msn.comCumberland County sheriff denies claims that tactical team was intoxicated during Lewiston shooting responseMay 27, 2024 | msn.comSmall plane crashes in Cumberland County, multiple people injuredMay 27, 2024 | msn.comLake Cumberland marina heavily damaged by stormsMay 27, 2024 | msn.comNew Cumberland residents come together for Memorial DayMay 27, 2024 | yahoo.comPlane engulfed in flames after crash near Gray’s Creek Airport in Cumberland County, witnesses sayMay 27, 2024 | msn.com3 people injured in plane crash in Cumberland CountyMay 27, 2024 | msn.comSolicitor arrested in Cumberland Co. for allegedly assaulting, shouting slurs at driverMay 27, 2024 | msn.comNearly 2K Cumberland Electric customers without power after strong stormsMay 27, 2024 | nj.comSee all homes sold in Cumberland County, May 20 to May 26May 27, 2024 | msn.comSmall plane crashes, becomes engulfed, injuring multiple people in Cumberland County near Fayetteville.May 26, 2024 | yahoo.comPlane crash in Cumberland County reportedly leaves three injured Sunday morningMay 26, 2024 | yahoo.comNearly 10K Cumberland Electric customers without power after strong stormMay 26, 2024 | yahoo.comCumberland University masters program meets milestonesMay 25, 2024 | msn.comPart of I-83 in Cumberland County reopens after multi-vehicle crashMay 25, 2024 | msn.comMan accused of trying to rob Cumberland Farms in Boston at gunpointMay 24, 2024 | msn.comPart of I-83 in Cumberland County closed after multi-vehicle crashMay 24, 2024 | msn.comCumberland House, Sask., in state of emergency due to impassable highwayMay 24, 2024 | nj.com10 most expensive homes sold in Cumberland County, May 13-19May 23, 2024 | msn.comMan arrested after victim texts 'help' to Cumberland County policeMay 23, 2024 | yahoo.comCumberland man jailed on felony assault chargeSee More Headlines Receive CPIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/07/2024Today6/09/2024Next Earnings (Estimated)8/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceuticals Current SymbolNASDAQ:CPIX CUSIP23077010 CIK1087294 Webwww.cumberlandpharma.com Phone(615) 255-0068Fax615-255-0094Employees91Year Founded1999Profitability EPS (Most Recent Fiscal Year)($0.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,280,000.00 Net Margins-21.67% Pretax Margin-21.52% Return on Equity0.21% Return on Assets0.08% Debt Debt-to-Equity Ratio0.59 Current Ratio1.37 Quick Ratio1.21 Sales & Book Value Annual Sales$39.55 million Price / Sales0.50 Cash Flow$0.69 per share Price / Cash Flow2.01 Book Value$1.96 per share Price / Book0.71Miscellaneous Outstanding Shares14,190,000Free Float8,046,000Market Cap$19.72 million OptionableOptionable Beta0.23 Social Links Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. A. J. Kazimi MBA (Age 66)Founder, Chairman, President & CEO Comp: $952.53kMr. John Michael Hamm (Age 68)VP & CFO Comp: $258.38kMr. James Lowrance Herman (Age 69)Executive VP of National Accounts & Chief Compliance Officer Comp: $372.27kMr. Chris T. Bitterman (Age 59)Vice President of Sales & Marketing Comp: $290.87kMr. Todd M. Anthony (Age 63)Vice President of Organizational Development Comp: $304.94kMs. Jean W. Marstiller (Age 74)Senior VP of Administrative Services & Corporate Secretary Comp: $282.17kMr. Adam S. Mostafa (Age 44)Managing Director Ms. Erin Smith GullSenior Corporate Relations AssociateMore ExecutivesKey CompetitorsAssembly BiosciencesNASDAQ:ASMBRecro PharmaNASDAQ:REPHEli Lilly and CompanyNYSE:LLYJohnson & JohnsonNYSE:JNJMerck & Co., Inc.NYSE:MRKView All Competitors CPIX Stock Analysis - Frequently Asked Questions How have CPIX shares performed in 2024? Cumberland Pharmaceuticals' stock was trading at $1.7917 at the beginning of the year. Since then, CPIX shares have decreased by 22.4% and is now trading at $1.39. View the best growth stocks for 2024 here. Are investors shorting Cumberland Pharmaceuticals? Cumberland Pharmaceuticals saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 29,200 shares, an increase of 59.6% from the April 30th total of 18,300 shares. Based on an average trading volume of 10,300 shares, the short-interest ratio is currently 2.8 days. Currently, 0.4% of the company's shares are short sold. View Cumberland Pharmaceuticals' Short Interest. When is Cumberland Pharmaceuticals' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 13th 2024. View our CPIX earnings forecast. How were Cumberland Pharmaceuticals' earnings last quarter? Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced its quarterly earnings data on Tuesday, May, 7th. The specialty pharmaceutical company reported ($0.06) earnings per share for the quarter. The specialty pharmaceutical company earned $8.50 million during the quarter. Cumberland Pharmaceuticals had a negative net margin of 21.67% and a positive trailing twelve-month return on equity of 0.21%. What is A. J. Kazimi's approval rating as Cumberland Pharmaceuticals' CEO? 9 employees have rated Cumberland Pharmaceuticals Chief Executive Officer A. J. Kazimi on Glassdoor.com. A. J. Kazimi has an approval rating of 9% among the company's employees. This puts A. J. Kazimi in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Cumberland Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cumberland Pharmaceuticals investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), CymaBay Therapeutics (CBAY), Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), VBI Vaccines (VBIV), Akero Therapeutics (AKRO), Cerecor (CERC), Xeris Biopharma (XERS). Who are Cumberland Pharmaceuticals' major shareholders? Cumberland Pharmaceuticals' stock is owned by a variety of retail and institutional investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include A J Kazimi, A J Kazimi, Caroline Young, James Jones, Joseph C Galante, Kenneth Krogulski, Martin E Cearnal, Martin E Cearnal and William Sumas. View institutional ownership trends. How do I buy shares of Cumberland Pharmaceuticals? Shares of CPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CPIX) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cumberland Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cumberland Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.